Bibliographic Details
Title: |
Mpox and Chickenpox Coinfection: Case Series From Southern Nigeria. |
Authors: |
Mmerem, Juliet I, Umenzekwe, Chukwudi C, Johnson, Simon M, Onukak, Asukwo E, Chika-Igwenyi, Nneka M, Chukwu, Sunday K, Onyeaghala, Chizaram A, Ozougwu, Jideofor J, Alasia, Datonye, Ehiakhamen, Odianosen, Nwankwo, Henry M, Ezejiofor, Ogochukwu I, Unigwe, Uche S, Iroezindu, Michael O |
Source: |
Journal of Infectious Diseases; 2024 Supplement, Vol. 229, pS260-S264, 5p |
Subject Terms: |
MONKEYPOX, CHICKENPOX, CHICKENPOX vaccines, MIXED infections, MONKEYPOX vaccines |
Geographic Terms: |
NIGERIA |
Abstract: |
Background We describe clinicoepidemiologic characteristics of mpox-chickenpox coinfection in Nigeria. Methods A retrospective cohort analysis was performed of confirmed mpox cases in Nigeria from January 2022 to March 2023. Mpox and chickenpox were confirmed by real-time polymerase chain reaction (RT-PCR). Results Of 94 (60.0%) suspected cases, 56 had confirmed mpox, of whom 16 (28.6%) had chickenpox coinfection. The median age of confirmed mpox cases was 29 years (interquartile range, 20–37 years), 24 were men (60.7%), 6 (10.7%) were bisexual, and 5 (8.9%) died. Mpox-chickenpox–coinfected patients had more complications than mpox-monoinfected cases (56.3% vs 22.5%, P =.015). Conclusions The high frequency of mpox-chickenpox coinfection argues for accelerated access to mpox and chickenpox vaccines in Africa. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
Database: |
Complementary Index |